Acorda Therapeutics, Inc. Embedded Derivative, Loss on Embedded Derivative
Acorda Therapeutics, Inc. reported Embedded Derivative, Loss on Embedded Derivative of $39.96 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Notes › Embedded Derivative
us-gaap:EmbeddedDerivativeLossOnEmbeddedDerivative · last filed 2021-03-16
- Acorda Therapeutics, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2020-12-31 was -$361.00K.
- Acorda Therapeutics, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2020-09-30 was $4.86M.
- Acorda Therapeutics, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2020-06-30 was $8.93M.
- Acorda Therapeutics, Inc. embedded derivative, loss on embedded derivative for the quarter ending 2020-03-31 was $26.53M.
- Acorda Therapeutics, Inc. embedded derivative, loss on embedded derivative for fiscal 2020 was $39.96M.
| Period end | Embedded Derivative, Loss on Embedded Derivative 3 month | Embedded Derivative, Loss on Embedded Derivative 6 month | Embedded Derivative, Loss on Embedded Derivative 9 month | Embedded Derivative, Loss on Embedded Derivative 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $4.50M derived: sum of 2 quarters · filed 2021-03-16 | $13.43M derived: sum of 3 quarters · filed 2021-03-16 | $39.96M 10-K · filed 2021-03-16 |
| 2020-09-30 | $4.86M 10-Q · filed 2020-11-06 | $13.79M derived: sum of 2 quarters · filed 2020-11-06 | $40.32M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $8.93M 10-Q · filed 2020-08-07 | $35.46M 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | $26.53M 10-Q · filed 2020-05-08 |